TABLE 2.
Likelihood of Switching Among Established Users of Bipolar Therapy*
Adjusted Odds Ratios | ||||||
---|---|---|---|---|---|---|
Maine (n = 5336) | New Hampshire (n = 1376) | Risk Ratios (ME Versus NH) | ||||
Phase-in Versus Prepolicy† |
Post Versus Prepolicy |
Phase-in Versus Prepolicy |
Post Versus Prepolicy |
Phase-in Versus Prepolicy |
Post Versus Prepolicy |
|
All established users | 1.19 (1.04, 135)‡ | 1.13 (1.00, 1.29) | 1.15 (0.88, 1.51) | 1.27 (0.96, 1.67) | 1.03 (0.76, 139) | 0.90 (0.66, 1.22) |
Using preferred agents prior to switch | 1.19 (0.90, 1.57) | 0.82 (0.63, 1.06) | 0.92 (0.56, 1.51) | 1.04 (0.64, 1.69) | 1.29 (0.73, 2.28) | 0.78 (0.45, 1.35) |
Using nonpreferred agents prior to switch | 1.06 (0.90, 1.25) | 1.12 (0.95, 1.31) | 1.16 (0.81, 1.68) | 1.31 (0.91, 1.89) | 0.91 (0.61, 1.36) | 0.85 (0.57, 1.26) |
Generalized Estimating Equations models control for age, gender, Medicare/Medicaid dual enrollment status, number of unique medications, and inpatient hospitalizations during the past 6 months.
Prepolicy, July 2002 to April 2003; phase-in period, May 2003 to July 2003; policy, August 2003 to February 2004.
P [H11021] 0.05.